Overview Fundamentals API Earnings EOD API Sample Code Pricing

Inhibrx, Inc. Ex-distribution When-Issued (INBXV NASDAQ) stock market data APIs

$30.85 0(0%) as of July 15, 2024
Price chart is built with Anychart

Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidate includes INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also develops INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.

Inhibrx, Inc. Ex-distribution When-Issued Financial Data Overview

Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'INBXV',
Type: 'Common Stock',
Name: 'Inhibrx, Inc. Ex-distribution When-Issued',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: NULL,
CIK: '1739614',
EmployerIdNumber: NULL,
FiscalYearEnd: NULL,
IPODate: '2024-05-28',
InternationalDomestic: NULL,
Sector: '',
Industry: '',
HomeCategory: NULL,
IsDelisted: false,

Inhibrx, Inc. Ex-distribution When-Issued Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Inhibrx, Inc. Ex-distribution When-Issued Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Inhibrx, Inc. Ex-distribution When-Issued End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?